FDA NDC Directory · JSON-LD · Markdown

ZYNLONTA

NDC 79952-110 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nameloncastuximab tesirine
Labeler / ManufacturerADC Therapeutics America, Inc.
Marketing categoryBiologic License Application · App BLA761196
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsLONCASTUXIMAB TESIRINE (10 mg/2mL)
Marketing started20210430
Package count1

External sources

Source: openFDA. Public-domain (CC0).